Optimizing patient access with evidence of product value, effectiveness, and safety from early development through loss of exclusivity.

Learn More
Latest News

Evidera to Acquire Medimix, Expanding Solutions for Real-World Research

Read the Press Release
Upcoming Conference

Meet with us at DIA 2019, June 23 - 24, San Diego, CA, USA

Schedule a meeting with us or stop by booth #2323 to speak with our experts

View Our DIA Presentations
White Paper

Can Early Collaboration between Multiple European Stakeholders Increase Access for Patients Living with Rare Diseases?

Learn how integrated regulatory and HTA scientific advice can help rare disease evidence planning to increase access for patients

Read Now
eBook

An Analysis of the Framework for the FDA's Real-World Evidence Program

What does this new framework mean for you?

Read Now
Policy Trends Update

CADTH Launches Parallel Scientific Advice Programs with NICE and Health Canada

Read about the recent discussion Evidera's Policy Trends team had with CADTH on new opportunities for scientific advice

Access the Full Interview

Our Work In Action

150+ Drugs/Therapies

supported in the past year

30+ Global Extended Access Programs

in the last 3 years alone with thousands of patients transitioning smoothly from investigational to commercial

130+ Payer Submissions

across 20+ countries in the past 5 years, including reversal of multiple NICE decisions

17 of the 20 Top-Selling Drugs

in 2018 supported in the past 5 years

130+ Peer-Reviewed Publications

and 220+ research posters and presentations per year

Learn More

Latest Publications

Oncology

Safety and Effectiveness of Classical and Alternative Sunitinib Dosing Schedules for Metastatic Renal Cell Carcinoma: A Meta-Analysis

  • Future Oncology
  • June 2019
Neurology

Development and Validation of the FSIQ-RMS: A New Patient-Reported Questionnaire to Assess Symptoms and Impacts of Fatigue in Relapsing Multiple Sclerosis

  • Value Health
  • June 2019
Any

Quantifying Preferences in Drug Benefit-Risk Decisions

  • Clinical Pharmacology and Therapeutics
  • June 2019
Read More About Our Publications
What We Do

What We Do

Real-World Evidence

Obtain real-world evidence of value by extracting data from existing sources, collecting primary data, and conducting hybrid studies.

Patient-Centered Research

Develop and evaluate clinical outcomes assessments to support labeling and promotional claims.

Evidence Synthesis, Modeling & Communication

Provide a truly connected value story, supported by strong evidence

Market Access

Optimize market access with cogent payer insights, expert-informed evidence strategy, and persuasive communication of product value.

Interventional Studies

Provide peri- and post-approval evidence via dedicated global operations and custom-tailored study designs.

Pragmatic Studies

Explore patient-centered outcomes and comparative effectiveness using pragmatic studies with adaptive designs.

Medical Writing

Expert medical writing, including medical information, study documentation, and publications, tailored to the peri- and post-approval environment.
Anuraag Kansal, PhD, Sr. Research Leader & Director, Disease & Trial Simulation, Modeling & Simulation at Evidera

In Our Own Words

Our work simulating Alzheimer’s disease progression allows us to offer clients insight into their trial designs, simulate outcomes of alternative designs, and enable clients to anticipate results and make decisions accordingly.

CUP Case Study
Case Study

Robust Modeling Helped Convince NICE to Reverse Their Decision

Learn how Evidera’s experts helped to improve access to a mCRPC treatment in a country with traditionally conservative reimbursement for these therapies.

Read More
Case Study

Compassionate Use Program: Rapid Drug Delivery to Patients in Need

Learn how Evidera, as part of PPD, created a global program across 38 countries to provide treatment within 24-48 hours to 3,100 patients.

Read More
Careers

Meaningful Work at Every Level

We assess candidates across a variety of scientific and operational functions. From leaders in their fields, to those who are new to the industry. We employ people who have a proactive mind-set when it comes to the work they do and helping the people they work with.

Learn More